Authoritative Legal Blog | Law Offices of Timothy L. Miles

Image of world map and financial data processing against time-lapse of night city traffic. Global finance and business technology concept

Wise Group Class Action Lawsuit: The Benefits of Securities Class Action Lawsuits

August 10, 2026 No Comments

Introduction to the Wise Group Class Action Lawsuit The Wise Group class action lawsuit seeks to represent purchasers or acquirers of Wise Group plc (NASDAQ: WSE) publicly traded securities between May 11, 2026 and July 23, 2026, inclusive (the “Class Period”). Captioned Daugherty v. Wise Group plc, No. 26-cv-06582 (S.D.N.Y.), the Wise Group class action lawsuit charges Wise Group and certain of Wise Group’s top

3d stock chart out side of city street used in Securities Litigation and

Primoris Class Action Lawsuit: The Benefits of Securities Class Action Lawsuits

August 10, 2026 No Comments

Introduction to the Primoris Class Action Lawsuit The Primoris class action lawsuit seeks to represent purchasers or acquirers Primoris Services Corporation (NYSE: PRIM) common stock between August 5, 2025 and June 22, 2026, inclusive (the “Class Period”). Captioned Boston Retirement System v. Primoris Services Corporation, No. 26-cv-02416 (N.D. Tex.), the Primoris class action lawsuit charges Primoris and certain of Primoris’ top current and former executives with violations of the Securities Act

Asia stock market and economic business growth

Alarum Class Action Lawsuit: The Fundamentals of Securities Litigation

August 9, 2026 No Comments

Introduction to the Alarum Class Action Lawsuit The Alarum class action lawsuit seeks to represent purchasers or acquirers of Alarum Technologies Ltd. (NASDAQ: ALAR) publicly traded securities between March 20, 2025 and July 2, 2026, inclusive (the “Class Period”). Captioned Cygler v. Alarum Technologies Ltd., No. 26-cv-09884 (D.N.J.), the Alarum class action lawsuit charges Alarum and certain of Alarum’s top executive officers with violations of the Securities Exchange Act of

Medicine and health concept. On the table is a stethoscope and a blue cube with the inscription - MEDICAL LAW

Dupixent Cancer Lawsuits Update (Aug. 2026)

August 9, 2026 No Comments

Dupixent Cancer Lawsuits Update (Aug. 2026) Dupixent Cancer Lawsuits Update: are being filed and investigated against Dupixent (dupilumab) manufacturers Sanofi and Regeneron, alleging the biologic drug increases the risk of cutaneous T-cell lymphoma (CTCL) and other T-cell lymphomas, or can “mask” early cancer symptoms, and that the companies failed to provide adequate warnings. Current Status of the Dupixent Lawsuits Individual Lawsuits:

Timothy L. Miles | Free Case Evaluation

Take Action: Call Today

"It will be the only call you need to make."

(855) 846-6529 Free Case Review Email Attorney Miles